Drug major Cipla on Thursday said Samina Hamied has decided to step down from the position of Executive Vice Chairperson of the company, wh...

Price closed above previous gap down area suggest further upsides in coming sessions.

Cipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 72606.20 Crore) operating in Pharmaceuticals sector.

Cipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 77400.61 Crore) operating in Pharmaceuticals sector.

Cipla Executive Vice-Chairperson Samina Vaziralli said with the government returning for a second consecutive five-year term armed with a s...

Sell Cipla Ltd. at a price target of Rs 625 and a stop loss at Rs 651 from the entry point.

Buy Cipla at a price target of Rs 625 and a stop loss at Rs 605 from entry point.

Hamied celebrated his 81st birthday last week.

Buy Cipla Ltd. at a price target of Rs 582.0 and a stop loss at Rs 558.0 from entry point

Buy Cipla Ltd. at a price target of Rs 565.0 and a stop loss at Rs 546.6 from entry point

The transfer of shares is being done by way of gift, the filing said, adding that the purpose was "Re-alignment of family shareholding".

Pharma major Cipla has urged the government to focus on supporting capital investment, encouraging R&D and create a favourable tax regime.

Cipla's promoter family has proposed to vote together as a single unit under overall direction of patriarch Yusuf Hamied in his lifetime, a...

Cipla's development and regulatory approval processes are on track. Currently, there are over 200 development projects underway indicating ...

For patenting of frivolous patents, unjustified patents, India is taking a very-very strong stand on that issue which will only help patien...

Pharma major Cipla Ltd today said it is hopeful of achieving 12-15 per cent revenue growth in the current financial year.

Pharma firm Cipla Ltd said it is looking to export Antiflu, the drug used in the treatment of influenza AH1N1 (swine flu) virus, to US mark...